Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M66,241Revenue $M6,300Net Margin (%)18.5Z-Score11.0
Enterprise Value $M64,208EPS $3.3Operating Margin %26.2F-Score7
P/E(ttm))51.9Cash Flow Per Share $4.6Pre-tax Margin (%)25.6Higher ROA y-yY
Price/Book9.310-y EBITDA Growth Rate %15.5Quick Ratio3.7Cash flow > EarningsY
Price/Sales9.65-y EBITDA Growth Rate %27.6Current Ratio3.9Lower Leverage y-yY
Price/Cash Flow20.1y-y EBITDA Growth Rate %1.7ROA % (ttm)12.0Higher Current Ratio y-yN
Dividend Yield %0.1Insider Buy (3m)0ROE % (ttm)19.7Less Shares Outstanding y-yN
Payout Ratio %5.0Shares Outstanding M298ROI % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNAndreas Halvorsen 2014-09-30 Add1.04%$151.92 - $179.7
($165.84)
$ 222.3634%Add 183.77%2,279,736
AGNRichard Perry 2014-09-30 Sold Out -7.8%$151.92 - $179.7
($165.84)
$ 222.3634%Sold Out0
AGNJohn Paulson 2014-09-30 Reduce-0.16%$151.92 - $179.7
($165.84)
$ 222.3634%Reduce -4.01%5,377,200
AGNJoel Greenblatt 2014-09-30 Reduce-0.02%$151.92 - $179.7
($165.84)
$ 222.3634%Reduce -65.17%5,670
AGNJean-Marie Eveillard 2014-09-30 Reduce-0.01%$151.92 - $179.7
($165.84)
$ 222.3634%Reduce -66.67%10,000
AGNBill Ackman 2014-06-30 Add38%$116.63 - $173.95
($155.63)
$ 222.3643%Add 4733.79%28,878,538
AGNRichard Perry 2014-06-30 Buy 7.8%$116.63 - $173.95
($155.63)
$ 222.3643%New holding, 1667625 sh.1,667,625
AGNJohn Paulson 2014-06-30 Buy 4.1%$116.63 - $173.95
($155.63)
$ 222.3643%New holding, 5602000 sh.5,602,000
AGNAndreas Halvorsen 2014-06-30 Buy 0.59%$116.63 - $173.95
($155.63)
$ 222.3643%New holding, 803369 sh.803,369
AGNJean-Marie Eveillard 2014-06-30 Buy 0.01%$116.63 - $173.95
($155.63)
$ 222.3643%New holding, 30000 sh.30,000
AGNRay Dalio 2014-06-30 Sold Out -0.02%$116.63 - $173.95
($155.63)
$ 222.3643%Sold Out0
AGNBill Ackman 2014-03-31 Buy 0.88%$110.28 - $131.43
($121.38)
$ 222.3683%New holding, 597431 sh.597,431
AGNAndreas Halvorsen 2014-03-31 Sold Out -0.75%$110.28 - $131.43
($121.38)
$ 222.3683%Sold Out0
AGNGeorge Soros 2014-03-31 Sold Out -0.09%$110.28 - $131.43
($121.38)
$ 222.3683%Sold Out0
AGNJoel Greenblatt 2014-03-31 Reduce-0.04%$110.28 - $131.43
($121.38)
$ 222.3683%Reduce -46%18,843
AGNRay Dalio 2014-03-31 Reduce-0.02%$110.28 - $131.43
($121.38)
$ 222.3683%Reduce -54.57%18,499
AGNAndreas Halvorsen 2013-12-31 Buy 0.75%$88.48 - $110.85
($95.35)
$ 222.36133%New holding, 1438989 sh.1,438,989
AGNFrank Sands 2013-12-31 Sold Out -1.9%$88.48 - $110.85
($95.35)
$ 222.36133%Sold Out0
AGNRay Dalio 2013-12-31 Reduce-0.14%$88.48 - $110.85
($95.35)
$ 222.36133%Reduce -81.99%40,719
AGNJoel Greenblatt 2013-12-31 Reduce-0.09%$88.48 - $110.85
($95.35)
$ 222.36133%Reduce -45.01%34,897
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AGN Andreas Halvorsen 2014-09-302,279,7360.771.6+183.77%
AGN Bill Ackman 2014-09-3028,878,5389.6938.3
AGN Ken Fisher 2014-09-306,01500-2.72%
AGN John Paulson 2014-09-305,377,2001.814-4.01%
AGN Mario Gabelli 2014-09-30123,9380.040.12-5.53%
AGN Dodge & Cox 2014-09-303,26400-8.42%
AGN Joel Greenblatt 2014-09-305,67000.01-65.17%
AGN Jean-Marie Eveillard 2014-09-3010,00000-66.67%
AGN Richard Perry 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$0view
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8244.88view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.779.59view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7979.47view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3578.67view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3978.61view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6678.23view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7479.54view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.481.47view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5282.76view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
Aegean Metals Group Inc. Announces Closing of Arrangement Jan 16 2015 
Aegean Commences Drilling at Hot Maden Gold-Copper Project, Eastern Turkey Dec 15 2014 
Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
Guru Bill Ackman Is Having a Very Good Year Nov 10 2014 
Aegean Metals Group & Mariana Resources Limited Sign Plan of Arrangement Nov 05 2014 
Aegean Metals Group Inc. Closes Non-Brokered Private Placement with Lead Order Oct 23 2014 
Bill Ackman's New Interview With Bloomberg Oct 13 2014 
Ackman's Pershing Square Now Available To The Public Oct 13 2014 
Bill Ackman's Midas Touch Oct 10 2014 
Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share Oct 10 2014 


More From Other Websites
Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog Jan 27 2015
Allergan sets up meeting to seek shareholder OK of Actavis acquisition Jan 26 2015
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC Jan 26 2015
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC Jan 26 2015
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC Jan 26 2015
Thursday's Market Recap Jan 22 2015
Lieff Cabraser Announces Class Action Litigation Against Allergan Inc. - AGN Jan 22 2015
Hungry Actavis pauses to digest Allergan Jan 21 2015
Valeant chief Pearson admits 'miscalculation' in Allergan pursuit Jan 21 2015
Cramer's Stop Trading: ACT doesn't quit Jan 21 2015
This Giant Drug Firm Won't Invent Medicines. Investors Are Cheering Jan 21 2015
UPDATE - AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving... Jan 20 2015
Asanko Gold Announces C$40 Million Bought Deal Financing Jan 20 2015
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog Jan 19 2015
Hospira Submits Retacrit Regulatory Application to the FDA - Analyst Blog Jan 16 2015
AstraZeneca Announces Encouraging Data from Brilinta Study - Analyst Blog Jan 15 2015
Asanko Gold Mine Construction Update Jan 15 2015
Roche to Acquire Up to 56% Interest in Foundation Medicine - Analyst Blog Jan 14 2015
Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog Jan 14 2015
Farallon Capital raises stake in Allergan Jan 14 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK